// App-Quantinova.ai

: Dry powder inhaled ribavirin in healthy volunteers: safety, tolerability, lung and systemic pharmacokinetics

Researchers

Presenter

  • Julia Billiard

Principal Investigators

  • Stephen Baker

  • Vijayalakshmi Chandrasekaran

  • Frans van den Berg

  • Shuying Yang

  • Etienne Dumont

Medical Centers

  • GlaxoSmithKline plc, Collegeville, United States of America

  • Hammersmith Medicines Research, London, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • Ribavirin

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Pharmacokinetics

  • Double Blind/Blinded

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved